Ajanta Pharma Promoter Releases 2,600 Shares from Pledge

Ravi Agrawal, trustee of Ravi Agrawal Trust and a promoter of Ajanta Pharma Limited, has reported the release of a pledge on 2,600 equity shares. The disclosure, made under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, indicates the release occurred on July 9, 2026. The reason cited for the release is 'Excess Pledge'. The shares were originally pledged for business financing with HSBC Direct Invest Financial Services Pvt Ltd. and held through Barclays Securities (India) Private Limited. This action impacts the promoter's encumbered shareholding.